Double-blind placebo-controlled study of terazosin in patients with chronic abacterial prostatitis


Cite item

Full Text

Abstract

A double-blind placebo-controlled trial of teraosin efficacy (Kornam, Lek, Slovenia) was made in 51 patients with chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) of category Ilia according to NIH. All the patients were given a 2-week induction course of placebo followed by teraosin treatment (5 mg/day, n = 29) or placebo (n = 22) for 8 weeks. The participants of the study were followed up for 12 months. Pretreatment differences between the groups by NIH-CPSI system, symptoms frequency scale, leukocyte count of the prostate and uroflowmetry were insignificant. Teraosin and placebo patients showed a noticeable improvement (39.7 and 9.9% by symptoms frequency scale, respectively; by 36.4 and 6.6% by the linear scale, respectively). The drug reduced pain and dysuria, improved quality of life considerably (by 36.2%). Maximal urine flow accelerated by 22.96 and 10.01% in teraosin and placebo groups, respectively. Leukocyte count fell two-fold in the study group and lowered insignificantly in the placebo group. The recurrence-free interval was 25 and 9 weeks, respectively. Thus, teraosin monotherapy improves quality of life in CAP/CPPS patients, significantly relieves symptoms and prolongs recurrence-free interval vs placebo.

About the authors

A V Sivkov

V N Oschepkov

A A Egorov

References

  1. Peters Т. J., Donovan J. L., Kay H. E. et al. The international Continence Society "Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms. J. Urol. (Baltimore). 1997; 157: 885-889.
  2. Scarpa R. M. Lower urinary tract symptoms (LUTS): what are the implications for the patients? Eur. Urol. 2001; 40 (suppl. 4): 12-20.
  3. Price D. Potential mechanism of action of superselective a-1adrenoreceptor antagonist. Eur. Urol. 2001; 40 (suppl. 4): 5- 11.
  4. Hampel C., Dolber P. C., Smith M. P. et al. Modulation of bladder alphal-adrenergic receptor subtype expression by bladder outlet obstruction. J. Urol. (Baltimore). 2002; 167: 1513-1521.
  5. Kaplan S. A., Ikeguchi E. F., Santarosa R. P. et al. Etiology of voiding dysfunction in men less than 50 yars of age. Urology. 1996; 47: 836-839.
  6. Сивков А. В., Егоров А. А., Ромих В. В. Псевдодиссинергия и синдром хронической тазовой боли у больных хроническим абактериальным простатитом. Существует ли взаимосвязь? Материалы Пленума правления РОУ, Саратов 8- 10 июня 2004. М.: 2004. 260-261.
  7. Mehik A., Hellstrom P., Lukkarinen О. et al. Increased intraprostatic pressure in patients with chronic prostatitis. Urol. Res. 1999; 27 (4): 227-229.
  8. Kirby R. S., Lowe D., Bultitude M. L., Shuttleworth К. Е. Intraprostatic urinary reflux: an etiological factor in abacterial prostatitis. Br. J. Urol. 1982; 54: 729-731.
  9. Litwin M. S., McNaughton-Collins M., Fowler F. J. J. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urol. (Baltimore). 1999; 162: 369-375.
  10. Osborn D. E., George N. J. R., Rao P. N. et al. Prostatodynia: physiological characteristics and rationale management with muscle relaxants. Br. J. Urol. 1987; 53: 621-623.
  11. Weiss S. G, Moon T. D. a-Blocker therapy. In: Nickel J. С ed. Textbook of prostatitis. Oxford; 1999. 319-327.
  12. Nickel J. C., Narayan P., McKay J. et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial, J. Urol. (Baltimore). 2004; 171: 1594-1597.
  13. Ткачук В. Н., Аль-Шукри С. X., Кузнецова М. И., Торосян О. Р. Тамсулозин в лечении больных хроническим простатитом. Урология. 2000; 5: 18-20.
  14. Сивков А. В., Ощепков В. И., Егоров А. А. Применение а,адреноблокаторов у больных хроническим простатитом. Consilium Medicum. 2002; 4: 385-390.
  15. Лопаткин Н. А., Аполихин О. И., Сивков А. В. и др. Результаты монотерапии теразозином пациентов хроническим неинфекционным простатитом. Урология. 2002; 5 (приложение): 37-52.
  16. Nickel J. С., Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. / J. Urol. (Baltimore). 1996; 155: 1950-1955.
  17. Ощепков В. Н., Дарий Е. В., Сивков А. В. Стандартизированная оценка симптомов хронического простатита. В кн.: Вопросы андрологии в урологии. М.: НИИ урологии МЗ РФ. 2000; 11: 100-109.
  18. True L. D., Berger R. E., Rothman I. et al. Prostate histopathology and the chronic prostatitis / chronic pelvic pain syndrome: a prospective biopsy study. J. Urol. (Baltimore). 1999; 34 (6): 457-466.
  19. Svihra J., Elias В., Javorka K. Jr., Kliment J. Diagnosis and treatment of functional disorders of the lower urinary tract in younger men. Bratisl. Lek. Listy. 2000; 101 (5): 302-305.
  20. Liao L. M., Shi B. Y., Liang С. Q. Ambulatory urodynamic monitoring of external urethral sphincter behavior in chronic prostatitis patients. Asian J. Androl. 1999; 1 (4): 215-217.
  21. Hetrick D., Ciol M., Turner J. et al. Pelvic muscle evaluation in men with chronic pelvic pain and controls. AUA 2002. Abstr. on CD-Rom.
  22. Сивков А. В., Ощепков В. Н., Егоров А. А. Терапия хронического абактериального простатита. В кн.: Тезисы Пленума правления Российского общества урологов, Саратов 8-10 июня 2004. Саратов; 2004. 216-230.
  23. Neal D. E., Moon Т. D. Use of terasosin in prostatodynia and validation of symptom score questionnaire. Urology. 1994; 43: 460-465.
  24. Cheah P. Y., Liong M. E., Yuen K. H. et al. Long-terra effectiveness of terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). AUA 2003. Abstr. on CD-Rom.
  25. Gul O., Eroglu M., Ozok U. Use of terazosine in patients with chronic pelvic pain syndrome evaluation bv prostatitis svmptom score index. Int. Urol. Nephrol. 2001; 32'(3): 433-436.
  26. Лопаткин Н. А., Сивков А. В., Аполихин О. И. и др. Хронический простатит. CD-ROM, НИИ урологии МЗ РФ; 20О4.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2005 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies